Nitric oxide is the mediator of tachykinin NK3 receptor-induced relaxation in the circular muscle of the guinea-pig ileum.
The tachykinin NK3 receptor agonist, senktide, produces concentration-dependent contraction of the circular muscle of the guinea-pig ileum (EC50 2.59 nM). In the presence of the blocker of neuronal type of voltage-sensitive calcium channels, omega-conotoxin (0.1 microM), the contractile response to a low concentration of senktide was converted to an inhibitory effect on spontaneous activity of the ileum. This inhibitory effect was further enhanced in the presence of atropine (1 microM) and was abolished by tetrodotoxin (1 microM), indicating its neural origin. In the presence of atropine and omega-conotoxin, the inhibitory response to senktide (1 nM) was greatly inhibited or even abolished by L-nitroarginine (30 microM), its effect being prevented by L-arginine but not by D-arginine (300 microM in each case). Apamin (0.1 microM) failed to significantly affect the inhibitory response to senktide. Apamin enhanced spontaneous activity of the preparation while L-nitroarginine had no effect. Neither apamin nor L-nitroarginine affected the inhibitory response to isoprenaline. These findings indicate that inhibition of circular muscle activity produced through NK3 receptor stimulation in the guinea-pig ileum is mediated through a neuronal pathway involving nitric oxide or a nitric oxide-like substance(s) generation.
Maggi
C A
CA
Pharmacology Department, A. Menarini Pharmaceuticals, Florence, Italy.
Patacchini
R
R
Meini
S
S
Giuliani
S
S
D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives / Q000494:pharmacology; D006168:Guinea Pigs; D007082:Ileum / Q000294:innervation / Q000502:physiology*; D066298:In Vitro Techniques; D008297:Male; D009126:Muscle Relaxation; D009130:Muscle, Smooth / Q000294:innervation / Q000502:physiology*; D009569:Nitric Oxide / Q000502:physiology*; D019335:Nitroarginine; D010446:Peptide Fragments / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology; D018042:Receptors, Neurokinin-3 / Q000502:physiology*; D013373:Substance P / Q000031:analogs & derivatives / Q000494:pharmacology; D014660:Vasoactive Intestinal Peptide / Q000378:metabolism; D020960:omega-Conotoxins
D010446:Peptide Fragments; D010455:Peptides; D018042:Receptors, Neurokinin-3; D020960:omega-Conotoxins; C054724:senktide; C053423:Conus magus toxin; D019335:Nitroarginine; D009569:Nitric Oxide; D013373:Substance P; D014660:Vasoactive Intestinal Peptide; D001120:Arginine